Soleno Therapeutics, Inc. operates as clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. It focuses on the treatment of metabolic and neurobehavioral disorder. It offers its lead candidate, Diazoxide Choline Controlled-Release (DCCR), an oral tablet for the treatment of Prader-Willi Syndrome (PWS). The company was founded on August 25, 1999 and is headquartered in Redwood City, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
182
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Soleno Therapeutics Inc market cap is $2.76B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Soleno Therapeutics Inc 52 week high is $90.32 as of November 17, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Soleno Therapeutics Inc 52 week low is $29.43 as of November 17, 2026.
Soleno Therapeutics Inc stock price today is $53.01.
Soleno Therapeutics Inc stock price yesterday was $52.99.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Soleno Therapeutics Inc's P/E ratio is 30.09.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Soleno Therapeutics Inc P/B ratio is 5.5296.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Soleno Therapeutics Inc 50-day moving average is $47.68.